Trial Profile
A phase III study of ALZT-OP1 in patients with evidence of Early Dementia Due to Suspected Alzheimer's Disease
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2015
Price :
$35
*
At a glance
- Drugs Ibuprofen+sodium cromoglicate (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 17 Sep 2015 New trial record